9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_003070.5(SMARCA2):​c.705_707dupGCA​(p.Gln236dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0321 in 150,494 control chromosomes in the GnomAD database, including 130 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q236Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.032 ( 130 hom., cov: 26)
Exomes 𝑓: 0.017 ( 34 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA2
NM_003070.5 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.00

Publications

9 publications found
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
  • intellectual disability-sparse hair-brachydactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003070.5
BP6
Variant 9-2039776-A-ACAG is Benign according to our data. Variant chr9-2039776-A-ACAG is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 436797.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0657 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA2NM_003070.5 linkc.705_707dupGCA p.Gln236dup disruptive_inframe_insertion Exon 4 of 34 ENST00000349721.8 NP_003061.3
SMARCA2NM_001289396.2 linkc.705_707dupGCA p.Gln236dup disruptive_inframe_insertion Exon 4 of 34 NP_001276325.1
SMARCA2NM_139045.4 linkc.705_707dupGCA p.Gln236dup disruptive_inframe_insertion Exon 4 of 33 NP_620614.2
SMARCA2NM_001289397.2 linkc.705_707dupGCA p.Gln236dup disruptive_inframe_insertion Exon 4 of 33 NP_001276326.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA2ENST00000349721.8 linkc.705_707dupGCA p.Gln236dup disruptive_inframe_insertion Exon 4 of 34 5 NM_003070.5 ENSP00000265773.5

Frequencies

GnomAD3 genomes
AF:
0.0321
AC:
4824
AN:
150394
Hom.:
131
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0679
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0168
Gnomad ASJ
AF:
0.0208
Gnomad EAS
AF:
0.0179
Gnomad SAS
AF:
0.0199
Gnomad FIN
AF:
0.0457
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0148
Gnomad OTH
AF:
0.0315
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0168
AC:
24355
AN:
1445666
Hom.:
34
Cov.:
28
AF XY:
0.0170
AC XY:
12189
AN XY:
718498
show subpopulations
African (AFR)
AF:
0.0687
AC:
2248
AN:
32738
American (AMR)
AF:
0.0151
AC:
644
AN:
42710
Ashkenazi Jewish (ASJ)
AF:
0.0172
AC:
445
AN:
25858
East Asian (EAS)
AF:
0.0172
AC:
663
AN:
38448
South Asian (SAS)
AF:
0.0202
AC:
1715
AN:
84904
European-Finnish (FIN)
AF:
0.0422
AC:
2179
AN:
51666
Middle Eastern (MID)
AF:
0.0214
AC:
119
AN:
5568
European-Non Finnish (NFE)
AF:
0.0136
AC:
15026
AN:
1104074
Other (OTH)
AF:
0.0220
AC:
1316
AN:
59700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
1778
3557
5335
7114
8892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0321
AC:
4837
AN:
150494
Hom.:
130
Cov.:
26
AF XY:
0.0327
AC XY:
2405
AN XY:
73466
show subpopulations
African (AFR)
AF:
0.0679
AC:
2774
AN:
40884
American (AMR)
AF:
0.0172
AC:
260
AN:
15126
Ashkenazi Jewish (ASJ)
AF:
0.0208
AC:
72
AN:
3462
East Asian (EAS)
AF:
0.0179
AC:
91
AN:
5082
South Asian (SAS)
AF:
0.0199
AC:
94
AN:
4712
European-Finnish (FIN)
AF:
0.0457
AC:
474
AN:
10362
Middle Eastern (MID)
AF:
0.0137
AC:
4
AN:
292
European-Non Finnish (NFE)
AF:
0.0148
AC:
1003
AN:
67582
Other (OTH)
AF:
0.0312
AC:
65
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
211
421
632
842
1053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00920
Hom.:
12

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 18, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 08, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Apr 24, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
Mutation Taster
=86/14
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113070757; hg19: chr9-2039776; COSMIC: COSV61806568; COSMIC: COSV61806568; API